These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11495486)

  • 41. The equivalence of compressor pressure-flow relationships with respect to jet nebulizer aerosolization characteristics.
    Standaert TA; Bohn SE; Aitken ML; Ramsey B
    J Aerosol Med; 2001; 14(1):31-42. PubMed ID: 11495483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerosol drug delivery: developments in device design and clinical use.
    Rottier B; Grasmeijer F; Hagedoorn P; de Boer AH
    Lancet; 2011 Sep; 378(9795):981-2; author reply 982. PubMed ID: 21907858
    [No Abstract]   [Full Text] [Related]  

  • 44. Liquid atomizing: nebulizing and other methods of producing aerosols.
    Lange CF; Finlay WH
    J Aerosol Med; 2006; 19(1):28-35. PubMed ID: 16551212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aerosol administration of antibiotics.
    Smith AL; Ramsey B
    Pediatr Pulmonol Suppl; 1995; 11():68-9. PubMed ID: 7547353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.
    Kamalaporn H; Leung K; Nagel M; Kittanakom S; Calvieri B; Reithmeier RA; Coates AL
    Pediatr Pulmonol; 2014 Jun; 49(6):574-80. PubMed ID: 23843366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebulizer therapy for children: the device-patient interface.
    Rubin BK
    Respir Care; 2002 Nov; 47(11):1314-9; discussion 1319-20. PubMed ID: 12425746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High frequency acoustic nebulization for pulmonary delivery of antibiotic alternatives against Staphylococcus aureus.
    Marqus S; Lee L; Istivan T; Kyung Chang RY; Dekiwadia C; Chan HK; Yeo LY
    Eur J Pharm Biopharm; 2020 Jun; 151():181-188. PubMed ID: 32315699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrapulmonary administration of medications.
    Bayat M; Cook AM
    J Neurosci Nurs; 2004 Aug; 36(4):231-5. PubMed ID: 15366551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An animal exposure system using ultrasonic nebulizer that generates well controlled aerosols from liquids.
    Serita F
    Ind Health; 1999 Jan; 37(1):82-7. PubMed ID: 10052304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.
    Andrade F; Rafael D; Videira M; Ferreira D; Sosnik A; Sarmento B
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1816-27. PubMed ID: 23932923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nebulization of drugs in a nasal CPAP system.
    Smedsaas-Löfvenberg A; Nilsson K; Moa G; Axelsson I
    Acta Paediatr; 1999 Jan; 88(1):89-92. PubMed ID: 10090555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A history of nebulization.
    Dessanges JF
    J Aerosol Med; 2001; 14(1):65-71. PubMed ID: 11495487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey.
    Alves J; Alp E; Koulenti D; Zhang Z; Ehrmann S; Blot S; Bassetti M; Conway-Morris A; Reina R; Teran E; Sole-Lleonart C; Ruiz-Rodríguez M; Rello J;
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):785-794. PubMed ID: 29318460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drugs by inhalatory route: an overview and upcoming clinical perspectives.
    Melillo EM; Balzano G
    Monaldi Arch Chest Dis; 1996 Oct; 51(5):405-12. PubMed ID: 9009629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhaled antimicrobial chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():v-vii. PubMed ID: 25907147
    [No Abstract]   [Full Text] [Related]  

  • 57. [Good practice for aerosol therapy by nebulisation].
    Dautzenberg B; Becquemin MH; Chaumuzeau JP; Diot P;
    Rev Mal Respir; 2007 Jun; 24(6):751-7. PubMed ID: 17632434
    [No Abstract]   [Full Text] [Related]  

  • 58. [Good practice for aerosol therapy by nebulization in 2020].
    Dubus JC; Becquemin MH; Vecellio L; Chaumuzeau JP; Reychler G;
    Rev Mal Respir; 2021 Feb; 38(2):171-176. PubMed ID: 33288396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhaled antibodies: formulations require specific development to overcome instability due to nebulization.
    Mayor A; Thibert B; Huille S; Respaud R; Audat H; Heuzé-Vourc'h N
    Drug Deliv Transl Res; 2021 Aug; 11(4):1625-1633. PubMed ID: 33768475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
    Rello J; Solé-Lleonart C; Rouby JJ; Chastre J; Blot S; Poulakou G; Luyt CE; Riera J; Palmer LB; Pereira JM; Felton T; Dhanani J; Bassetti M; Welte T; Roberts JA
    Clin Microbiol Infect; 2017 Sep; 23(9):629-639. PubMed ID: 28412382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.